Table 1.
Characteristic | Histologic Subtype (N = 2,923) |
Fisher's Exact P | |||
---|---|---|---|---|---|
Ductal (n = 2,599) |
Lobular (n = 324) |
||||
No. | % | No. | % | ||
Chemotherapy strata | .01 | ||||
No chemotherapy | 2,059 | 79.2 | 237 | 73.1 | |
Received chemotherapy | 540 | 20.8 | 87 | 26.9 | |
Random assignment strata | .001 | ||||
4-arm | 1,880 | 72.3 | 262 | 80.9 | |
2-arm | 719 | 27.7 | 62 | 19.1 | |
Subtype | < .001 | ||||
Lum A | 1,436 | 55.3 | 237 | 73.1 | |
Lum B | 1,163 | 44.7 | 87 | 26.9 | |
Age, years | .19 | ||||
≤ 55 | 584 | 22.5 | 86 | 26.5 | |
56-70 | 1,638 | 63.0 | 199 | 61.4 | |
≥ 71 | 377 | 14.5 | 39 | 12.0 | |
Obese (BMI ≥ 30 kg/m2) | .93 | ||||
No | 1,929 | 74.2 | 243 | 75.0 | |
Yes | 561 | 21.6 | 67 | 20.7 | |
Unknown | 109 | 4.2 | 14 | 4.3 | |
Nodal status | .29 | ||||
Nx/N0 | 1,473 | 56.7 | 178 | 54.9 | |
N1-N3 | 709 | 27.3 | 83 | 25.6 | |
≥ N4 | 417 | 16.0 | 63 | 19.4 | |
Tumor size, cm | < .001 | ||||
< 2 | 1,685 | 64.8 | 158 | 48.8 | |
≥ 2 | 905 | 34.8 | 162 | 50.0 | |
Missing | 9 | 0.3 | 4 | 1.2 | |
Tumor grade (centrally assessed) | < .001 | ||||
1 | 553 | 21.3 | 13 | 4.0 | |
2 | 1,443 | 55.5 | 309 | 95.4 | |
3 | 589 | 22.7 | 2 | 0.6 | |
Missing | 14 | 0.5 | — | — | |
Peritumoral invasion (centrally assessed) | < .001 | ||||
No | 2,304 | 88.6 | 317 | 97.8 | |
Yes | 285 | 11.0 | 7 | 2.2 | |
Missing | 10 | 0.4 | — | — | |
Treatment assigned | .32 | ||||
Letrozole | 1,300 | 50.0 | 152 | 46.9 | |
Tamoxifen | 1,299 | 50.0 | 172 | 53.1 | |
Local therapy | < .001 | ||||
LTM/RT | 1,426 | 54.9 | 145 | 44.8 | |
LTM/no RT | 85 | 3.3 | 4 | 1.2 | |
Mastectomy/RT | 423 | 16.3 | 86 | 26.5 | |
Mastectomy/no RT | 663 | 25.5 | 88 | 27.2 | |
Other | 2 | 0.1 | 1 | 0.3 |
Abbreviations: BMI, body mass index; LTM: less than mastectomy; Lum A, luminal A; Lum B, luminal B; RT, radiotherapy.